Nicole Warner, MS CCC-SLP in Cambridge, NE - Speech-Language Pathologist

Nicole Warner, MS CCC-SLP is a Speech-language Pathologist based in Cambridge, Nebraska. Nicole Warner is licensed to practice in Nebraska (license number 707) and her current practice location is 1003 Nelson St, Cambridge, Nebraska. She can be reached at her office (for appointments etc.) via phone at (308) 697-3322.

NPI number for Nicole Warner is 1972105781 and her current mailing address is 1003 Nelson St, Cambridge, Nebraska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1972105781.

Contact Information

	Nicole Warner, MS CCC-SLP
	1003 Nelson St, Cambridge, NE 69022-3525
	(308) 697-3322
	Not Available

Healthcare Provider's Profile

Full Name	Nicole Warner
Gender	Female
Speciality	Speech-language Pathologist
Location	1003 Nelson St, Cambridge, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1972105781
Provider Enumeration Date: 11/16/2020
Last Update Date: 11/16/2020

Medical Identifiers

Medical identifiers for Nicole Warner such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1972105781	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	707 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Nicole Warner is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Nicole Warner, MS CCC-SLP 1003 Nelson St, Cambridge, NE 69022-3525 Ph: (308) 697-3322	Nicole Warner, MS CCC-SLP 1003 Nelson St, Cambridge, NE 69022-3525 Ph: (308) 697-3322

News Archive

Feds announce comprehensive plan to combat painkiller abuse

The new strategy will put increased pressure on the state of Florida, which has a reputation as being "the nation's pill mill."

Cedarlane to distribute TGR's new ELISA-One technology assay reagents in Canada and the US

TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Cedarlane Laboratories of Burlington, ON, Canada, a leading supplier of Life Science research reagents in North America.

WHO, UNICEF issue guide, call for more research into medicines for children

Along with the release of a WHO-UNICEF guide on medicines for children, the U.N. agencies on Friday said the guide "exposed dangerous shortfalls" in medicines designed for children and called for more research into treating children, Reuters reports. "While effective medicines exist to fight disease and treat life-threatening conditions like malnutrition, formulations suitable for children are often difficult to source," Francisco Blanco, UNICEF's chief of medicines and nutrition, said, according to the news service.

U.S. healthcare practitioners can resume use of Rotarix, says FDA

GlaxoSmithKline announced that the Food and Drug Administration has determined that U.S. healthcare practitioners can resume the use of Rotarix (Rotavirus Vaccine, Live, Oral), effective immediately. This action supersedes the FDA's recommendation from March 22, 2010 and reflects the agency's assessment that the presence of porcine circovirus type 1 in the vaccine poses no safety risk.

Nicole Warner, MS CCC-SLP - Speech-Language Pathologist in Cambridge, NE